Genomics of Kidney Transplantation

Inclusion Criteria: * Kidney (or kidney-pancreas) transplant recipient no more than 10 days post-transplant or kidney donor no more than 30 days post-transplant or previously enrolled in Phase I of the Genomics of Kidney Transplantation Study; * No organs other than kidney or pancreas transplanted simultaneously with the qualifying kidney transplant; and * Participant or parent/guardian must be able to understand and provide written informed consent. Inclusion for the Activity and mRNA Expression Cohort: * Recipient enrolled in the Main Cohort Study; * Informed consent for participation in the Activity and mRNA Expression Cohort; * Age 18 years or greater as of day of transplantation;and * Will receive tacrolimus, cyclosporine or mycophenolate as part of maintenance immunosuppression therapy. Exclusion Criteria: \- Inability or unwillingness of the participant or parent/guardian to give a written informed consent or comply with the study protocol. For the Activity and mRNA Expression Cohort: \- Inability or unwillingness of the participant or parent/guardian to give a written informed consent for participation in the Activity and mRNA Expression Cohort or comply with the study protocol.